#ESMO26 🧬 Presidential | 🇨🇳 ARTEMIS-011

👥 122 pts | R/R osteosarcoma
💊 Ris-Rez (B7-H3 ADC) vs gemcitabine/docetaxel

📈 mPFS: 5.5 vs 1.4 mo (HR 0.33)
🎯 ORR: 15% vs 2%
✅ DCR: 76% vs 33%
⏳ OS immature (HR 0.51)

⚠️ G≥3 TRAEs: 93% vs 83%

💡 Promising new strategy!

@OncoAlert